Clinical Trials List
2023-11-01 - 2030-12-31
Phase III
Not yet recruiting4
Recruiting2
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/17
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 陳彥蓁 Division of General Surgery
- 邱仁輝 Division of General Surgery
- 賴亦貞 Division of General Surgery
- 馮晉榮 Division of General Surgery
- 林燕淑 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 陳柏方 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- 鄭涵方 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chen-Teng Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- Yao-Chung Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 王國鐘 Division of General Surgery
- 楊陽生 Division of Hematology & Oncology
- 楊捷儒 Division of General Surgery
- 林慈恩 Division of General Surgery
- Kuan-Der Lee Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- Huey-En Tzeng Division of Hematology & Oncology
- I-Chen Tsai Division of General Surgery
- HSIN-CHEN LIN Division of Hematology & Oncology
- 劉佳樺 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Wei-Wu Chen Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 林柏翰 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 李佳真 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 楊明翰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
1050 participants
